SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (OnlineFirst PDF)
Right arrow All Versions of this Article:
0269881106075275v1
21/5/553    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lang, U. E.
Right arrow Articles by Felber, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lang, U. E.
Right arrow Articles by Felber, W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

Charles Bonnet Syndrome: Successful treatment of visual hallucinations due to vision loss with selective serotonin reuptake inhibitors

Undine E. Lang1*, Dariusz Stogowski1, Doreen Schulze1, Markus Domula1, Eckart Schmidt2, Jüergen Gallinat3, Sems Malte Tugtekin4, Werner Felber1

1 Department of Psychiatry, University of Dresden, Dresden, Germany.
2 Department of Ophthalmology, University of Dresden, Dresden, Germany.
3 Psychiatric Department, Charité University Medicine, Campus Mitte, Germany.
4 Department of Cardiac Surgery, Heart Centre Dresden, Dresden, Germany.

* To whom correspondence should be addressed.


   Abstract

Visual hallucinations are a common and often distressing consequence of vision loss, particularly in age-related macular degeneration. Charles Bonnet Syndrome (CBS) is defined by the triad of complex visual hallucinations, ocular pathology causing visual deterioration and preserved cognitive status. So far, although this condition is frequent, no established treatment for CBS has been stated. We report here the case of a 78-year-old woman, who came in our hospital because of a 4-week long mild depressive symptomatology. For 1 year she experienced daily sudden, unexpected, vivid and elaborate hallucinations. Insight was completely present, so the patient stated that the hallucinations were unreal and that the faces, geometrical figures and animals she saw every day were possibly due to her vision loss. The Mini Mental State Examination, digit span and verbal fluency were administered and no cognitive impairment was reported. The visual acuity was hand motion. After 4 days of treatment with venlafaxine the hallucinations completely disappeared. This is the first case to show that selective serotonin (and noradrenalin) reuptake inhibitors may be an effective and well-tolerated treatment for visual hallucinations associated with vision loss, and it adds to evidence implicating serotonergic pathways in the pathogenesis of visual hallucinations.

Key Words: serotonin;Charles Bonnet Syndrome;CBS;hallucinations;epileptic;SSRI;venlafaxine;escitalopram

First published on April 19, 2007, doi:10.1177/0269881106075275

Journal of Psychopharmacology 2007;21:553.

A more recent version of this article appeared on July 1, 2007


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
CMAJHome page
M.L. Jackson and J. Ferencz
Charles Bonnet syndrome: visual loss and hallucinations
Can. Med. Assoc. J., August 4, 2009; 181(3-4): 175 - 176.
[Full Text] [PDF]



Advertisement